Sutcu H, Rassinoux P, Donnio L, Neuillet D, Vianna F, Gabillot O
Life Sci Alliance. 2023; 7(2).
PMID: 37993260
PMC: 10665522.
DOI: 10.26508/lsa.202302279.
Sutcu H, Montagne B, Ricchetti M
Cell Death Differ. 2023; 30(8):1900-1915.
PMID: 37400716
PMC: 10406879.
DOI: 10.1038/s41418-023-01177-2.
De Luca G, Ferretti R, Bruschi M, Mezzaroma E, Caruso M
Stem Cells. 2013; 31(11):2478-91.
PMID: 23897741
PMC: 3963451.
DOI: 10.1002/stem.1487.
Seurin D, Lombet A, Babajko S, Godeau F, Ricort J
PLoS One. 2013; 8(3):e59323.
PMID: 23527161
PMC: 3602172.
DOI: 10.1371/journal.pone.0059323.
Clemen C, Herrmann H, Strelkov S, Schroder R
Acta Neuropathol. 2012; 125(1):47-75.
PMID: 23143191
PMC: 3535371.
DOI: 10.1007/s00401-012-1057-6.
Polycomb-repressed genes have permissive enhancers that initiate reprogramming.
Taberlay P, Kelly T, Liu C, You J, De Carvalho D, Miranda T
Cell. 2011; 147(6):1283-94.
PMID: 22153073
PMC: 3240866.
DOI: 10.1016/j.cell.2011.10.040.
Proline isomerase Pin1 represses terminal differentiation and myocyte enhancer factor 2C function in skeletal muscle cells.
Magli A, Angelelli C, Ganassi M, Baruffaldi F, Matafora V, Battini R
J Biol Chem. 2010; 285(45):34518-27.
PMID: 20801874
PMC: 2966067.
DOI: 10.1074/jbc.M110.104133.
Exon skipping and duchenne muscular dystrophy therapy: selection of the most active U1 snRNA antisense able to induce dystrophin exon 51 skipping.
Incitti T, De Angelis F, Cazzella V, Sthandier O, Pinnaro C, Legnini I
Mol Ther. 2010; 18(9):1675-82.
PMID: 20551908
PMC: 2956936.
DOI: 10.1038/mt.2010.123.
Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells.
Angelelli C, Magli A, Ferrari D, Ganassi M, Matafora V, Parise F
Nucleic Acids Res. 2007; 36(3):915-28.
PMID: 18086704
PMC: 2241889.
DOI: 10.1093/nar/gkm1114.
Myocyte enhancer factor 2 activates promoter sequences of the human AbetaH-J-J locus, encoding aspartyl-beta-hydroxylase, junctin, and junctate.
Feriotto G, Finotti A, Volpe P, Treves S, Ferrari S, Angelelli C
Mol Cell Biol. 2005; 25(8):3261-75.
PMID: 15798210
PMC: 1069596.
DOI: 10.1128/MCB.25.8.3261-3275.2005.
Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy.
Rochat A, Fernandez A, Vandromme M, Moles J, Bouschet T, Carnac G
Mol Biol Cell. 2004; 15(10):4544-55.
PMID: 15282335
PMC: 519148.
DOI: 10.1091/mbc.e03-11-0816.
MyoD distal regulatory region contains an SRF binding CArG element required for MyoD expression in skeletal myoblasts and during muscle regeneration.
Lhonore A, Lamb N, Vandromme M, Turowski P, Carnac G, Fernandez A
Mol Biol Cell. 2003; 14(5):2151-62.
PMID: 12802082
PMC: 165104.
DOI: 10.1091/mbc.e02-07-0451.
SFRP2 expression in rabbit myogenic progenitor cells and in adult skeletal muscles.
Levin J, El Andalousi R, Dainat J, Reyne Y, Bacou F
J Muscle Res Cell Motil. 2002; 22(4):361-9.
PMID: 11808776
DOI: 10.1023/a:1013129209062.
Muscle specific fragile X related protein 1 isoforms are sequestered in the nucleus of undifferentiated myoblast.
Dube M, Huot M, Khandjian E
BMC Genet. 2001; 1:4.
PMID: 11178106
PMC: 29080.
DOI: 10.1186/1471-2156-1-4.
Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21.
Lawlor M, Rotwein P
Mol Cell Biol. 2000; 20(23):8983-95.
PMID: 11073997
PMC: 86552.
DOI: 10.1128/MCB.20.23.8983-8995.2000.
The 2'-5' oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation.
Bisbal C, Silhol M, Laubenthal H, Kaluza T, Carnac G, Milligan L
Mol Cell Biol. 2000; 20(14):4959-69.
PMID: 10866653
PMC: 85946.
DOI: 10.1128/MCB.20.14.4959-4969.2000.
cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.
Kitzmann M, Vandromme M, SCHAEFFER V, Carnac G, Labbe J, Lamb N
Mol Cell Biol. 1999; 19(4):3167-76.
PMID: 10082583
PMC: 84110.
DOI: 10.1128/MCB.19.4.3167.
The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells.
Kitzmann M, Carnac G, Vandromme M, Primig M, Lamb N, Fernandez A
J Cell Biol. 1998; 142(6):1447-59.
PMID: 9744876
PMC: 2141770.
DOI: 10.1083/jcb.142.6.1447.
RhoA GTPase and serum response factor control selectively the expression of MyoD without affecting Myf5 in mouse myoblasts.
Carnac G, Primig M, Kitzmann M, Chafey P, Tuil D, Lamb N
Mol Biol Cell. 1998; 9(7):1891-902.
PMID: 9658178
PMC: 25431.
DOI: 10.1091/mbc.9.7.1891.
Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts.
Lindon C, Montarras D, Pinset C
J Cell Biol. 1998; 140(1):111-8.
PMID: 9425159
PMC: 2132595.
DOI: 10.1083/jcb.140.1.111.